Physician profile
Derek Redinger
NPI 1265963698
$1,315.35
in general payments reported to CMS, 2019-2025
15 companies · $651 in 2025
The $651 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $48.65 · 2023: $292 · 2024: $324 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,266.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $211.36 | 2025 | Sapien 3 Ultra Resilia |
| Glaxosmithkline, LLC. | $200.31 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $196.24 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $164.82 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $128.72 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $85.43 | 2024-2025 | |
| Astellas Pharma US INC | $81.03 | 2025 | Veozah |
| Insmed, INC. | $57.48 | 2025 | Arikayce |
| Amgen INC. | $41.52 | 2023 | Repatha, Otezla, Prolia |
| Inspire Medical Systems, INC. | $36.66 | 2024 | Inspire |
| Merck Sharp & Dohme LLC | $31.42 | 2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Boston Scientific Corporation | $27.13 | 2024 | Watchman Flx |
| Teva Pharmaceuticals USA, INC. | $22.66 | 2022 | |
| Exact Sciences Corporation | $15.69 | 2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $14.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Redinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.